National Demographic Trends and Approval Rates for Omalizumab Use to Treat Food Allergy: A Retrospective Claims-Based Analysis Since FDA Approval

Abstract

Peer reviewed

Leo Wan, Mary Lee-wong, Robert Promisloff, Jacky Lin, Xiner Jiang, Karandeep Bawa and Anthony Szema

Journal of allergy and clinical immunology, v 155(2), AB139

Feb 2025

Files and links (1)

url

https://doi.org/10.1016/j.jaci.2024.12.443View

Published, Version of Record (VoR) Open

18 Record Views

Title: National Demographic Trends and Approval Rates for Omalizumab Use to Treat Food Allergy: A Retrospective Claims-Based Analysis Since FDA Approval
Creators: Leo Wan
Mary Lee-wong
Robert Promisloff
Jacky Lin
Xiner Jiang
Karandeep Bawa
Anthony Szema
Publication Details: Journal of allergy and clinical immunology, v 155(2), AB139
Publisher: Elsevier
Resource Type: Abstract
Language: English
Academic Unit: College of Medicine
Other Identifier: 991022027535904721